Ember LifeSciences raises $27.0M Series A (United States, May 2026)

Ember raises $27M to tackle drug and vaccine losses in cold chain - Stock Titan

Ember LifeSciences is a company focused on addressing drug and vaccine losses in the cold chain logistics sector. Their flagship product, the Ember Cube 2, is a reusable, modular shipping solution that offers real-time monitoring and cloud-based tracking, targeting costly temperature excursions in pharmaceutical logistics.

Ember raises $27M to tackle drug and vaccine losses in cold chain  Stock Titan